NOX 0.00% 7.0¢ noxopharm limited

Novartis Vision trial result, page-19

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    it means exactly that- yes Vision it’s in public domain but it’s unpublished in the sense that at present the trial results have been communicated in abstract form for Congress and via Novartis press release , not fully published in a journal - a non issue as I expect it will be.

    of course they won’t sue, they’ll be preoccupied meeting a worldwide regulatory submission process. It’s simply a poor look for Nox to ride Novartis coat tails in this way, imo. Comes across as a bit desperate.
    Hmmm... Lutetium arm of vision n= 550; Lupin n= 56. Ten fold sample size difference and the Nox crew claiming they’ve added further 4 months survival. Hmmm...
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.000(0.00%)
Mkt cap ! $20.45M
Open High Low Value Volume
7.0¢ 7.0¢ 7.0¢ $2.863K 40.90K

Buyers (Bids)

No. Vol. Price($)
1 141114 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 5000 1
View Market Depth
Last trade - 10.21am 20/06/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.